<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365115">
  <stage>Registered</stage>
  <submitdate>17/10/2013</submitdate>
  <approvaldate>14/11/2013</approvaldate>
  <actrnumber>ACTRN12613001253796</actrnumber>
  <trial_identification>
    <studytitle>A randomised controlled trial evaluating if antibiotics given before complex skin surgery on the ear,nose or below knee will prevent infection </studytitle>
    <scientifictitle>Do antibiotics given before complex skin surgery on the ear,nose or below knee prevent infection: a prospective randomized placebo-controlled double blinded trial.</scientifictitle>
    <utrn> U1111-1148-9139</utrn>
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Infection </healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>2g (in 4 capsules) cephalexin given orally 30-60 minutes prior to flap or graft surgery on the ear, nose or below knee</interventions>
    <comparator>Placebo (4 capsules containing microcrystalline cellulose and calcium carbonate- these look identical to those containing cephalexin)</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Infection within 30 days of surgery.
Research nurse will call participant 1 month following surgery to check if they were prescribed antibiotics for infection at surgical site of interest.
Antibiotics will be given if there is:
a) Purulent discharge from the incisional wound
b) Pain, heat or localised swelling
c) Erythema &gt; 1 cm from wound edges
A confirming swab will also be taken if infection is suspected </outcome>
      <timepoint>30 days</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>nil</outcome>
      <timepoint>nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>flap or graft surgery to nose, ear or below knee</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Infection at time of surgery; allergy to penicillin or cephalosporins; antibiotic use within 48hrs of surgery; wider excision if previously recruited to trial; allergy to sutures or dressings used in trial</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation concealment- identical looking capsules containing either placebo or antibiotic are placed into sealed numbered containers off-site (at compounding pharmacy). Allocation sequence will not be revealed to clinic staff or participants until cessation of trial</concealment>
    <sequence>Computerized sequence generation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>Currently infection rates for flap &amp; graft surgery on the ear in nose is 20%. It was assumed that with the intervention infection rates would drop to 4%.
To show this with statistical confidence (power in excess of 80%; significance level 0.05) 59 patients are required in each group. Allowing for 20% drop-out 142 in total will need to be recruited to each group (71 intervention &amp; 71 placebo).
For the below knee surgery component of the trial we anticipated a 25% infection rates for flap and graft closures below knee. Our hypothesis was that antibiotic prophylaxis would reduce infection rate to 5%.    Forty-four patients were required in each study group to show this with statistical confidence (power in excess of 80%; significance level 0.05).  We planned to recruit a minimum of 110 participants (55 intervention and 55 placebo) allowing for a 25% drop out
Data analysis will be by intention to treat. Bivariate statistical tests will be used to test whether the randomisation process was successful. If so, chi-square tests will be used to see if infection was less in the intervention group. If not multivariate logistic regression analysis will be used to assess the impact of the intervention on infection rates. </statisticalmethods>
    <masking1>False</masking1>
    <masking2>False</masking2>
    <masking3>False</masking3>
    <masking4>False</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>4/10/2013</anticipatedstartdate>
    <actualstartdate>4/12/2013</actualstartdate>
    <anticipatedenddate>31/10/2014</anticipatedenddate>
    <actualenddate>28/02/2016</actualenddate>
    <samplesize>252</samplesize>
    <actualsamplesize>252</actualsamplesize>
    <currentsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>25/03/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD</recruitmentstate>
    <postcode>4812 - Gulliver</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Skin Repair Skin Cancer Clinic</primarysponsorname>
    <primarysponsoraddress>66 Mooney St
Gulliver
Queensland 4812</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Skin Repair Skin cancer Clinic</fundingname>
      <fundingaddress>66 Mooney St
Gulliver
Queensland 4812</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Other Collaborative groups</fundingtype>
      <fundingname>Skin Cancer college of Australasia</fundingname>
      <fundingaddress>Level 8, East Wing, Wesley Hospital, 451 Coronation Drive, Auchenflower, Qld 4066</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this study is to discover if antibiotics given prior to complex surgery on the nose, ear or below knee prevents infection. </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Townsville Hospital and Health Services HREC</ethicname>
      <ethicaddress>Townsville Hospital and Health Services
Ground floor MediLink Building
The Townsville Hospital 
Douglas Qld 4914</ethicaddress>
      <ethicapprovaldate>20/09/2013</ethicapprovaldate>
      <hrec>13/QTHS/61</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Helena Rosengren</name>
      <address>James Cook University
School of Medicine
Townsville, QLD 4811</address>
      <phone>+61 7 4779 0099</phone>
      <fax>+61 7 4779 0098</fax>
      <email>helena@skinrepair.net.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Helena Rosengren</name>
      <address>James Cook University
School of Medicine
Townsville, QLD 4811</address>
      <phone>+61 7 4779 0099</phone>
      <fax>+61 7 4779 0098</fax>
      <email>helena@skinrepair.net.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Helena Rosengren</name>
      <address>James Cook University
School of Medicine
Townsville, QLD 4811</address>
      <phone>+61 7 4779 0099</phone>
      <fax>+61 7 4779 0098</fax>
      <email>helena@skinrepair.net.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>